Company / Operating Income
Catalyst Pharmaceuticals Partners, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$257.8M
FY2025
5-year range
$52.4M / $257.8M
FY2021-FY2025
Trend
+32.1%
vs FY2024
Sector context
#24 of 204
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s operating income of $258M is higher than 88% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$35M in FY2018 to $258M in FY2025.
Based on SEC 10-K filings.
$258M in FY2025 with a 5-year CAGR of +44.2%. Top quartile in the Health Care sector.
Improved from $87M to $258M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +36.3%
- 5-Year CAGR
- +44.2%
- 10-Year CAGR
- -
Sector benchmark
+139.3% above sector average
Key checks
Key Insights
- 5-year CAGR of +44.2%, indicating consistent growth.
- In FY2025, operating income increased 32.1% year-over-year.
- Ranks #24 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $257.8M | +32.1% |
| FY2024 | $195.1M | +124.8% |
| FY2023 | $86.8M | -14.8% |
| FY2022 | $101.8M | +94.4% |
| FY2021 | $52.4M | +26.8% |
| FY2020 | $41.3M | +29.8% |
| FY2019 | $31.8M | +190.2% |
| FY2018 | -$35.3M | -73.0% |
| FY2017 | -$20.4M | -5.8% |
| FY2016 | -$19.3M | +5.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026